APA

Pini A., Garella R., Idrizaj E., Calosi L., Baccari M. C. & Vannucchi M. G. (20170105). Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus. : Neurogastroenterology and motility.

Chicago

Pini A, Garella R, Idrizaj E, Calosi L, Baccari M C and Vannucchi M G. 20170105. Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus. : Neurogastroenterology and motility.

Harvard

Pini A., Garella R., Idrizaj E., Calosi L., Baccari M. C. and Vannucchi M. G. (20170105). Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus. : Neurogastroenterology and motility.

MLA

Pini A, Garella R, Idrizaj E, Calosi L, Baccari M C and Vannucchi M G. Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus. : Neurogastroenterology and motility. 20170105.